BIOBio-Rad Laboratories, Inc.

$389.08

What is the market doing?

What the tape says about BIO

Bio-Rad Laboratories, Inc. is +47% over the past year while the S&P 500 is +23%: 24 points ahead of the market.

+47%

1-year return · S&P 500 +23%

vs 200-day average
+29%

vs 200-day average · a clear uptrend

RSI (14)
84

RSI (14) · overbought, bought harder than it has been sold

Below its 52-week high
−0.31%

Below its 52-week high

2024-08-06$216.56 – $390.31 · dashed line: 200-day average2026-08-26
Details
Last close2026-08-26
$389.08
1 monthS&P 500 +3.7%
+23%
1 yearS&P 500 +23%
+47%
5 yearsS&P 500 +87%
−47%
vs 50-day average$320.73
+21%
52-week high
$390.31
52-week low
$241.71
Annualised volatility
41%
Insider buying, net, 6 monthsForms 3/4/5 to 2026-06-30
−$136K
Calendar-year price return
YearReturn
2026 (year to date)+28%
2025−7.8%
2024+1.7%
2023−23%
2022−44%
2021+30%
2020+58%
2019+59%
2018−2.7%
2017+31%
Average return by calendar month, 2016–2026
MonthYearsPositiveAverage
Jan105 of 10+1.3%
Feb107 of 10−0.89%
Mar105 of 10−0.65%
Apr106 of 10+0.90%
May106 of 10+1.7%
Jun106 of 10+0.01%
Jul1111 of 11+9.0%
Aug116 of 11+3.6%
Sep103 of 10−3.0%
Oct104 of 10−1.5%
Nov107 of 10+5.7%
Dec106 of 10−1.7%

End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.